Quality of a finished product should be the #1 concern of all manufacturers – and of all consumers. This is especially true in using peptides as therapeutic agents. Lower quality peptides can contain “fillers” like mannitol or contain impurities, which limit their effectiveness as therapeutic agents, reduce the effectiveness of our treatments as clinicians, AND place the patient at risk…